The University of Chicago Header Logo

Connection

Kenneth Gordon to Biological Products

This is a "connection" page, showing publications Kenneth Gordon has written about Biological Products.
Connection Strength

3.952
  1. Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis - Authors' reply. Lancet Rheumatol. 2023 Jun; 5(6):e313.
    View in: PubMed
    Score: 0.780
  2. Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study. Lancet Rheumatol. 2023 Apr; 5(4):e200-e207.
    View in: PubMed
    Score: 0.768
  3. Comparative Effectiveness Studies for Psoriasis-The Methods Matter. JAMA Dermatol. 2020 03 01; 156(3):253-255.
    View in: PubMed
    Score: 0.623
  4. Treating to Target-A Realistic Goal in Psoriasis? Semin Cutan Med Surg. 2018 Feb; 37(2S):S44-S47.
    View in: PubMed
    Score: 0.539
  5. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know? Dermatol Ther. 2009 Sep-Oct; 22(5):431-40.
    View in: PubMed
    Score: 0.301
  6. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020 Jan; 82(1):161-201.
    View in: PubMed
    Score: 0.152
  7. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019 Apr; 80(4):1029-1072.
    View in: PubMed
    Score: 0.145
  8. Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3. Br J Dermatol. 2018 08; 179(2):320-328.
    View in: PubMed
    Score: 0.138
  9. Practical Strategies for Optimizing Management of Psoriasis. Semin Cutan Med Surg. 2018 Feb; 37(2S):S52-S55.
    View in: PubMed
    Score: 0.135
  10. Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies. Br J Dermatol. 2018 01; 178(1):132-139.
    View in: PubMed
    Score: 0.134
  11. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008 May; 58(5):826-50.
    View in: PubMed
    Score: 0.069
  12. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008 May; 58(5):851-64.
    View in: PubMed
    Score: 0.069
  13. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. J Am Acad Dermatol. 2008 Jan; 58(1):94-105.
    View in: PubMed
    Score: 0.066
  14. The Evolving Landscape of Psoriasis Treatment. Semin Cutan Med Surg. 2018 Feb; 37(2S):S39-S43.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.